0001209191-22-007348.txt : 20220207 0001209191-22-007348.hdr.sgml : 20220207 20220207082720 ACCESSION NUMBER: 0001209191-22-007348 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220203 FILED AS OF DATE: 20220207 DATE AS OF CHANGE: 20220207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pons Jaume CENTRAL INDEX KEY: 0001816977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 22595554 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-02-03 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001816977 Pons Jaume C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2022-02-03 4 M 0 11900 0.99 A 456724 D Common Stock 2022-02-03 4 M 0 12254 1.91 A 468978 D Employee Stock Option (right to buy) 0.99 2022-02-03 4 M 0 11900 0.00 D 2027-03-30 Common Stock 11900 230279 D Employee Stock Option (right to buy) 1.91 2022-02-03 4 M 0 12254 0.00 D 2029-09-12 Common Stock 12254 6128 D Includes 226 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021. Shares subject to the option are fully vested and immediately exercisable. The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on June 16, 2019. /s/ Peter Garcia, by power of attorney 2022-02-07